Rheumatology Investigations and Management Flashcards

1
Q

What is the criteria for diagnosing RA?

A

ACR/EULAR classification criteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

RA investigations

A

Blood testing (anaemia, raised platelets)
Inflammatory markers
Autoantibodies (anti-CCP)
Imaging (x-ray, US, MRI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

RA management

A

DMARD (1st methotrexate, 2nd sulfasalazine, 3rd hydroxychloroquine)
Steroids (for exacerbations)
Biologics (if DAS28 greater than 5.1 on 2 occasions 4 weeks apart)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lupus diagnostic investigations

A
ANA
Anti-dsDNA
Anti-Sm
Antiphospholipid ab
Low complement
Direct coombs test (haemolytic anaemia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lupus organ involvement investigations (depend on symptoms)

A
CXR
Pulmonary function tests
CT chest
Urine protein quantification
Renal biopsy
Echocardiogram
Nerve conduction studies
MRI brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SLE management

A

NSAIDs and simple analgesia
Hydroxychloroquine (may reduce systemic complications)
Steroids (varying dose for complications)
DMARDs
Biologics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Raynauds management

A

Calcium channel blockers or PDE5 inhibitors (sildefanil)

If digital ulcers - prostacyclin analogues (iloprost), botox injections, endothelin receptor antagonists (bosentan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Systemic sclerosis management

A

Yearly ECHO and PFTs
Treat raynauds
Treat reflux (PPI)
Treat pulmonary fibrosis (immunosuppression)
Treat pulmonary hypertension (prostacyclin analogues, endothelin receptor antigonists, PDE5 inhibitors)
Tight blood pressure control (ACEI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sjogrens investigations

A
Antibodies (anti-ro and anti-la, ANA)
Salivary gland ultrasound and biopsy (if antibodies negative)
Inflammatory markers (high ESR/PV)
Raised IgG
Cytopaenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sjogrens management

A

Lubricants
Strong fluoride toothpaste
Hydroxychloroquine (if fatigue and arthralgia)
Immunosuppression for major organ involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antiphospholipid investigations

A

Autoantibodies (anti-cardiolipin, lupus anticoagulant, beta 2 glycoprotein)
Thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anti-phospholipid management

A

Lifelong anti-coagulation IF THROMBOSIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

General principles of CTD management

A

Assess disease severity
Urinalysis
CXR, PFT, ECHO
Manage cardiovascular risk factors
If major organ involvement - immunosuppression
If not - hydroxychloroquine, symptomatic management

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Poly/dermatomyositis investigations

A
Blood tests (CK, inflammatory markers, U&E, PTH, TSH)
Autoantibodies (ANA, anti-Jo-1)
Electromyography
Muscle biopsy (definitive test)
MRI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Poly/dermatomyositis management

A

Steroids (prednisolone)

Immunosuppressants (steroid sparing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Temporal arteritis/polymyalgia rheumatica investigations

A
Inflammatory markers (raised)
Temporal artery biopsy
17
Q

Temporal arteritis/polymyalgia rheumatica management

A

Low dose steroids in just polymyalgia rheumatica
Higher dose in temporal arteritis
Gradual reduction in dose around 18 months to 2 years

18
Q

Fibromyalgia management

A

Supportive/holistic therapy (including graded exercise therapy)
Antidepressants
Analgesia
Gabapentin/pregabalin

19
Q

What is the radiographic grading scale for OA?

A

Kellgren-lawrence

20
Q

OA management

A
Physiotherapy
Lifestyle advice
Analgesia
NSAIDs
Atypical pain killers
Intra-articular steroids
Surgery
21
Q

Gout investigations

A

Inflammatory markers (raised)
Serum uric acid (may be raised or normal)
Synovial fluid polarised microscopy (diagnostic)
X-rays

22
Q

Gout management

A

Acute: NSAID (colchicine second line)
Steroid

Prophylaxis: allopurinol or febuxostat (2-4 weeks after acute attack)
Need to take NSAID or colchicine as well.

23
Q

Pseudogout management

A

NSAIDs
Colchicine
Steroids
Rehydration

24
Q

Milkwaukee shoulder management

A

NSAIDs
Intra-articular steroid
Physiotherapy
Partial or total arthroplasty

25
Q

Score for hypermobility name

A

Modified beighton score

26
Q

Criteria for ank spon name

A

ASAS classification criteria

27
Q

Ank spon investigations

A

Inflammatory markers
HLA B27
X-ray

28
Q

Ank spon management

A

Physio/occupational therapy
NSAID
DMARDs if peripheral joint involvement
Anti-TNF/anti-IL17 if severe

29
Q

Psoriatic arthritis investigations

A

Inflammatory markers (raised)
Negative RF
X-rays (pencil in cup, enthesitis)

30
Q

Psoriatic arthritis management

A
NSAIDs
Steroid IA
DMARDs
Anti-TNF (if unresponsive to DMARDs)
Anti-IL17
31
Q

Reactive arthritis

A

Inflammatory markers
FBC/U&Es
HLA B27 (rarely necessary)
Cultures
Joint fluid analysis (rule out septic arthritis)
X-ray
Ophthalmology opinion (for eye involvement)

32
Q

Reactive arthritis management

A

NSAIDs
Corticosteroids (IA, oral, eye drops)
Antibiotics for underlying infection
DMARDs if resistant or chronic

33
Q

Enteropathic arthritis management

A
Treat inflammatory bowel disease (controls arthritis)
NO NSAID
Normal analgesia
Steroids
DMARDs
Anti-TNF
34
Q

Small vessel vasculitis investigations

A

ANCA, PR3, MPO (varies with disease activity)

C3/4

35
Q

Anca associated vasculitis management

A

Localised/early systemic - methotrexate and steroids
Generalised/systemic - cyclophosphamide and steroids
Refractory - IV immunoglobulins, rituximab

36
Q

HSP investigation and management

A

Self-limiting

Urinalysis to screen for renal involvement